RT Generic
T1 Endovascular treatment of the tricuspid valve: current status
A1 Parody-Cuerda, Gertrudis
A1 Rodriguez-Caulo, Emiliano
A1 Miguel Barquero-Aroca, Jose
K1 Tricuspid valve
K1 Tricuspid regurgitation
K1 Transcatheter tricuspid valve repair
K1 To-edge repair
K1 Transcatheter heart-valve
K1 1st-in-man implantation
K1 Initial-experience
K1 Early feasibility
K1 Regurgitation
K1 Outcomes
K1 System
K1 Annuloplasty
K1 Disease
AB According to the latest studies, the surgical intervention rate of the tricuspid valve is very low, despite the large number of patients with severe tricuspid regurgitation with indication for surgery according to clinical practice guidelines. Likewise, recent data demonstrate that isolated tricuspid valve surgery is significantly and independently associated with high mortality. New transcatheter thera pies are emerging to solve these issues. In the present work, a non-systematic review of the state of the art of the different percutaneous devices currently on the market was carried out, organized into three groups: valve with implant in orthotopic or heterotopic position, annuloplasty systems and coaptation systems. Thus, this document aims to offer a global vision of the current landscape and future perspectives of endovascular treatments of tricuspid valve disease, a field of great interest in full expansion. (C) 2021 Sociedad Espanola de Cirugia Cardiovascular y Endovascular. Published by Elsevier Espana, S.L.U.
PB Elsevier
SN 1134-0096
YR 2021
FD 2021-09-03
LK http://hdl.handle.net/10668/18735
UL http://hdl.handle.net/10668/18735
LA es
DS RISalud
RD Apr 8, 2025